This statistic displays the top pharmaceutical R&D projects based on net present value, as of December 2023. According to the source, the top R&D project was Novo Nordisk's fixed-dose combination for type 2 diabetes and obesity Cagrisema, with a net present value of over 30 billion U.S. dollars at that time.
Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2023
(in billion U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Evaluate Vantage. (December 21, 2023). Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2023 (in billion U.S. dollars) [Graph]. In Statista. Retrieved December 08, 2024, from https://www.statista.com/statistics/973453/most-valuable-randd-projects-by-npv/
Evaluate Vantage. "Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2023 (in billion U.S. dollars)." Chart. December 21, 2023. Statista. Accessed December 08, 2024. https://www.statista.com/statistics/973453/most-valuable-randd-projects-by-npv/
Evaluate Vantage. (2023). Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2023 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: December 08, 2024. https://www.statista.com/statistics/973453/most-valuable-randd-projects-by-npv/
Evaluate Vantage. "Selected Top Pharmaceutical R&d Projects Based on Net Present Value (Npv) as of December 2023 (in Billion U.S. Dollars)." Statista, Statista Inc., 21 Dec 2023, https://www.statista.com/statistics/973453/most-valuable-randd-projects-by-npv/
Evaluate Vantage, Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2023 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/973453/most-valuable-randd-projects-by-npv/ (last visited December 08, 2024)
Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2023 (in billion U.S. dollars) [Graph], Evaluate Vantage, December 21, 2023. [Online]. Available: https://www.statista.com/statistics/973453/most-valuable-randd-projects-by-npv/
